The Valley Desk

NCT06154252 · Interventional trial

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Overall registry status Recruiting

Phase 2 · Phase 3

Conditions Anti-Synthetase Syndrome, Dermatomyositis, Idiopathic Inflammatory Myopathy, Immune-Mediated Necrotizing Myopathy, Juvenile Dermatomyositis, Juvenile Idiopathic Inflammatory Myopathy (JIIM), Juvenile Myositis, Juvenile Polymyositis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov